Discovery, Optimization, and Evaluation of Novel N-(Benzimidazol-5-yl)-1,3,4-thiadiazol-2-amine Analogues as Potent STAT3 Inhibitors for Cancer Treatment
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Discovery, Optimization, and Evaluation of Novel N-(Benzimidazol-5-yl)-1,3,4-thiadiazol-2-amine Analogues as Potent STAT3 Inhibitors for Cancer Treatment
Authors
Keywords
-
Journal
JOURNAL OF MEDICINAL CHEMISTRY
Volume 66, Issue 17, Pages 12373-12395
Publisher
American Chemical Society (ACS)
Online
2023-08-18
DOI
10.1021/acs.jmedchem.3c00863
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Benzobis(imidazole) derivatives as STAT3 signal inhibitors with antitumor activity
- (2022) Yi-Chen Liu et al. BIOORGANIC & MEDICINAL CHEMISTRY
- The Multifaced Role of STAT3 in Cancer and Its Implication for Anticancer Therapy
- (2021) Manlio Tolomeo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- TTI-101: A competitive inhibitor of STAT3 that spares oxidative phosphorylation and reverses mechanical allodynia in mouse models of neuropathic pain
- (2021) Moses M. Kasembeli et al. BIOCHEMICAL PHARMACOLOGY
- Natural STAT3 inhibitors: A mini perspective
- (2021) Zhuo Wang et al. BIOORGANIC CHEMISTRY
- Distinct effects of general anesthetics on lung metastasis mediated by IL-6/JAK/STAT3 pathway in mouse models
- (2020) Ru Li et al. Nature Communications
- Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 to Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution
- (2020) Uddalak Bharadwaj et al. PHARMACOLOGICAL REVIEWS
- The STAT3 inhibitor Stattic acts independently of STAT3 to decrease histone acetylation and modulate gene expression
- (2020) Dipak K. Poria et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Targeting the IL-6/JAK/STAT3 signalling axis in cancer
- (2018) Daniel E. Johnson et al. Nature Reviews Clinical Oncology
- Phase I Dose-Finding Study of OPB-111077, a Novel STAT3 Inhibitor, in Patients with Advanced Hepatocellular Carcinoma
- (2018) Changhoon Yoo et al. Cancer Research and Treatment
- Discovery of an Orally Selective Inhibitor of Signal Transducer and Activator of Transcription 3 Using Advanced Multiple Ligand Simultaneous Docking
- (2017) Wenying Yu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Novel STAT 3 inhibitors for treating gastric cancer
- (2016) Catherine Cafferkey et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Alternative Roles of STAT3 and MAPK Signaling Pathways in the MMPs Activation and Progression of Lung Injury Induced by Cigarette Smoke Exposure in ACE2 Knockout Mice
- (2016) Yi-Han Hung et al. International Journal of Biological Sciences
- Signal transducer and activator of transcription 3 ( Stat3 ) regulates host defense and protects mice against herpes simplex virus-1 (HSV-1) infection
- (2016) Hung-Ching Hsia et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Targeting transcription factor STAT3 for cancer prevention and therapy
- (2016) Edna Zhi Pei Chai et al. PHARMACOLOGY & THERAPEUTICS
- Dihydroartemisinin as a Putative STAT3 Inhibitor, Suppresses the Growth of Head and Neck Squamous Cell Carcinoma by Targeting Jak2/STAT3 Signaling
- (2016) Lifeng Jia et al. PLoS One
- 1,3,4-Thiadiazole: Synthesis, Reactions, and Applications in Medicinal, Agricultural, and Materials Chemistry
- (2014) Yang Hu et al. CHEMICAL REVIEWS
- STAT3 in Cancer—Friend or Foe?
- (2014) Hai-Feng Zhang et al. Cancers
- Plasticity and cross-talk of Interleukin 6-type cytokines
- (2012) Christoph Garbers et al. CYTOKINE & GROWTH FACTOR REVIEWS
- New and unusual scaffolds in medicinal chemistry
- (2011) Charles M. Marson CHEMICAL SOCIETY REVIEWS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now